Remove 2012 Remove Medical Remove Supply Chain Remove Treatment Plan
article thumbnail

Why, Who, When, Where and More: New Draft Guidance on Notifying FDA about Discontinuance or Interruption in Manufacturing

FDA Law Blog

By Véronique Li, Senior Medical Device Regulation Expert & Deborah L. Early notification can play a role in decreasing the impact and duration of such supply disruptions and product shortages. API and its source and any alternative sources; associated medical devices), and expected duration of the interruption.